Status:
RECRUITING
SIBTime Phase II: Web Application for Typically Developing Siblings
Lead Sponsor:
Oregon Research Behavioral Intervention Strategies, Inc.
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Early Life Stress
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Most of the over 32.7 million people in the U.S. who have special health, developmental, and mental health concerns have typically developing (TD) brothers and sisters who share high levels of involve...
Detailed Description
An 8-week RCT will be conducted to evaluate the full-scale SIBTime program in a sufficiently powered randomized controlled trial evaluation (sample size = 160 parent/child dyads). SIBTime will be asse...
Eligibility Criteria
Inclusion
- Criteria:
- Inclusion criteria:
- Parent of a child with a disability and a typically developing child aged 3-6
- Has a smartphone or tablet
- Speaks English or Spanish
- Exclusion criteria:
- 1\. None
Exclusion
Key Trial Info
Start Date :
October 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06099457
Start Date
October 27 2023
End Date
January 31 2026
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
David R Smith
Springfield, Oregon, United States, 97477